Peter M Gordon

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 5

Top Topics

Gold Nanoparticles

Acute Lymphoblastic Leukemia

Top Venues

British journal of haematology

Bioconjugate chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Leslie M Jonart, Jason Ostergaard, Athena Brooks, Garrett Fitzpatrick, Liam Chen, Peter M Gordon
CXCR4 antagonists disrupt leukaemia-meningeal cell adhesion and attenuate chemoresistance. British journal of haematology (2022)
Leslie M Jonart, Jason Ostergaard, Athena Brooks, Garrett Fitzpatrick, Liam Chen, Peter M Gordon
CXCR4 antagonists disrupt leukaemia-meningeal cell adhesion and attenuate chemoresistance. British journal of haematology (2022)
Jason Ostergaard, Leslie M Jonart, Maryam Ebadi, Stacia L Koppenhafer, David J Gordon, Peter M Gordon
Preclinical efficacy of prexasertib in acute lymphoblastic leukemia. British journal of haematology 194 (6) (2021)
Maryam Ebadi, Justin Wasko, Daniel J Weisdorf, Peter M Gordon, Armin Rashidi
Ruxolitinib combined with chemotherapy can eradicate chemorefractory central nervous system acute lymphoblastic leukaemia. British journal of haematology 187 (1) (2019)
Jordan A Naumann, John C Widen, Leslie A Jonart, Maryam Ebadi, Jian Tang, David J Gordon, Daniel A Harki, Peter M Gordon
SN-38 Conjugated Gold Nanoparticles Activated by Ewing Sarcoma Specific mRNAs Exhibit In Vitro and In Vivo Efficacy. Bioconjugate chemistry 29 (4) (2018)